66 related articles for article (PubMed ID: 22388102)
21. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells.
Nimmanapalli R; Lyu MA; Du M; Keating MJ; Rosenblum MG; Gandhi V
Blood; 2007 Mar; 109(6):2557-64. PubMed ID: 17119117
[TBL] [Abstract][Full Text] [Related]
22. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
23. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.
Shivakumar L; Ansell S
Clin Lymphoma Myeloma; 2006 Sep; 7(2):106-8. PubMed ID: 17026820
[TBL] [Abstract][Full Text] [Related]
24. B-Lymphocyte stimulator: a new biomarker for multiple myeloma.
Jiang P; Yueguo W; Huiming H; Hongxiang Y; Mei W; Ju S
Eur J Haematol; 2009 Apr; 82(4):267-76. PubMed ID: 19187273
[TBL] [Abstract][Full Text] [Related]
25. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
[TBL] [Abstract][Full Text] [Related]
26. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
27. BLyS and B cell homeostasis.
Woodland RT; Schmidt MR; Thompson CB
Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
[TBL] [Abstract][Full Text] [Related]
28. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
29. Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells.
Choi AY; Choi JH; Yoon H; Hwang KY; Noh MH; Choe W; Yoon KS; Ha J; Yeo EJ; Kang I
Eur J Pharmacol; 2011 Oct; 668(1-2):115-26. PubMed ID: 21762691
[TBL] [Abstract][Full Text] [Related]
30. [Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells].
Qiu Q; Wang Z; Jiang JM; Li DD
Yao Xue Xue Bao; 2007 Feb; 42(2):132-8. PubMed ID: 17518039
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway.
Huang P; Yu C; Liu XQ; Ding YB; Wang YX; He JL
Int J Mol Med; 2011 Oct; 28(4):579-87. PubMed ID: 21687933
[TBL] [Abstract][Full Text] [Related]
32. Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate.
Gomez-Lazaro M; Galindo MF; Melero-Fernandez de Mera RM; Fernandez-Gómez FJ; Concannon CG; Segura MF; Comella JX; Prehn JH; Jordan J
Mol Pharmacol; 2007 Mar; 71(3):736-43. PubMed ID: 17172466
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine.
Boya P; Gonzalez-Polo RA; Poncet D; Andreau K; Vieira HL; Roumier T; Perfettini JL; Kroemer G
Oncogene; 2003 Jun; 22(25):3927-36. PubMed ID: 12813466
[TBL] [Abstract][Full Text] [Related]
34. Bax activation and translocation to mitochondria mediate EGF-induced programmed cell death.
Tikhomirov O; Carpenter G
J Cell Sci; 2005 Dec; 118(Pt 24):5681-90. PubMed ID: 16303853
[TBL] [Abstract][Full Text] [Related]
35. Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway.
Ji YB; Qu ZY; Zou X
Exp Toxicol Pathol; 2011 Jan; 63(1-2):69-78. PubMed ID: 19815401
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
Parameswaran R; Yu M; Lyu MA; Lim M; Rosenblum MG; Groffen J; Heisterkamp N
Leukemia; 2012 Aug; 26(8):1786-96. PubMed ID: 22373785
[TBL] [Abstract][Full Text] [Related]
37. An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA.
Tian Y; Zhu YF; Wu Z; Feng JN; Li Y; Shen BF; Sun J
Biotechnol Lett; 2013 Apr; 35(4):523-8. PubMed ID: 23242501
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma.
Wen X; Lyu MA; Zhang R; Lu W; Huang Q; Liang D; Rosenblum MG; Li C
Mol Imaging Biol; 2011 Aug; 13(4):721-9. PubMed ID: 20686856
[TBL] [Abstract][Full Text] [Related]
39. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.
Briones J; Timmerman JM; Hilbert DM; Levy R
Exp Hematol; 2002 Feb; 30(2):135-41. PubMed ID: 11823048
[TBL] [Abstract][Full Text] [Related]
40. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
Fu L; Lin-Lee YC; Pham LV; Tamayo A; Yoshimura L; Ford RJ
Blood; 2006 Jun; 107(11):4540-8. PubMed ID: 16497967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
